Skip to main content
Premium Trial:

Request an Annual Quote

Cetek Raises $10M in VC Financing

NEW YORK, Jan. 5 (GenomeWeb News) - Cetek raised $10 million from investors to advance its drug-discovery platform, the company said earlier this week.

 

Participating investors include Argonaut Private Equity, Ventry Industries, Gainesborough Investments, James L. Waters, and Stata Ventures. They are all current Cetek investors.

 

Cetek approaches drug discovery using high throughput capillary electrophoresis screening technology and chemical biology-focused drug source. The company said it uses its technologies through service agreements and collaborations.

 

The Marlborough, Mass-based company also announced a scientific advisory board. The chairman of the board is Cetek founder Barry L. Karger. Other members include K. Frank Austen from Harvard Medical School, James D. Griffin from Harvard Medical School, Charles L. Cooney, from the MIT Program on the Pharmaceutical Industry, and Martin S. Hirsch from Harvard School of Public Health; and Infectious Disease Service at the Massachusetts General Hospital.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more